#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myeloproliferative neoplasm Rhabdomyosarcoma Ocular lymphoma Dupuytren's contracture Primary mediastinal large B-cell lymphoma Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Hairy cell leukaemia Interstitial lung disease Neuropathy peripheral Small intestine neuroendocrine tumour Kaposi's sarcoma Acute graft versus host disease Krabbe's disease Retinal dystrophy Hepatic angiosarcoma More trials…

    Learn about Rare Diseases

    Phenylketonuria – Life with Disease Bronchopulmonary dysplasia – Treatment Hereditary motor and sensory neuropathy – Treatment Tuberous sclerosis complex – Basic Information Pituitary-dependent Cushing’s syndrome – Treatment Angelman’s syndrome – Trials in Disease Primary hyperoxaluria – Diagnostics Aicardi-Goutieres syndrome – Diagnostics Langerhans cell sarcoma – Basic Information Sarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lasmiditan Dexamethasone Acetate Clofutriben Benzyl Alcohol Enfuvirtide Bexotegrast [18F]-Altanserin Triptorelin Acetate Ponesimod Pitolisant Tianeptine Divarasib Gd2Il18Cart Triptorelin Bortezomib Efinopegdutide Dinoprostone Gliclazide Testosterone Undecanoate Anifrolumab More therapies…

    Learn about Your Condition

    Carotid arteriosclerosis Spinal osteoarthritis Acute on chronic liver failure Hypertrophic cardiomyopathy Schizoaffective disorder Desmoplastic melanoma Coma Uterine leiomyoma Electronic cigarette user Giant cell arteritis Proteus syndrome Post procedural complication Wolfram syndrome Dyspnoea Oesophagectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness of E. coli DSM 17252 for Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Irritable bowel syndrome
    Germany

  • Study on the Effectiveness and Safety of a Grass and Juniperus Oxycedrus Allergy Vaccine for Patients with Allergic Rhinitis or Rhinoconjunctivitis with or without Mild Asthma

    Recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Rhinitis allergic
    • Seasonal allergy
    Investigated Drugs:
    • Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified
    • Allergen Extract From Lolium Perenne Pollen, Glutaraldehyde-Modified
    • Allergen Extract From Phleum Pratense Pollen, Glutaraldehyde-Modified
    Spain

  • Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Oxaliplatin
    France

  • Study on Preventing Atrial Fibrillation Recurrence After Cardioversion Using Dapagliflozin in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Dapagliflozin Propanediol
    Sweden

  • Study on the Safety and Effectiveness of Tafasitamab for Children with Relapsed or Refractory Acute B Lineage Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Tafasitamab
    Germany

  • Study on Preoperative Aqueous Iodine Solution for Patients with Hyperthyroidism Due to Graves’ Disease and Toxic Nodular Goiter

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperthyroidism
    Sweden
Previous Page
1 … 341 342 343 344 345 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!